These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 27628783

  • 21. Antibiotic tolerance induced by lactoferrin in clinical Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Andrés MT, Viejo-Diaz M, Pérez F, Fierro JF.
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1613-6. PubMed ID: 15793153
    [Abstract] [Full Text] [Related]

  • 22. Potentiation of Tobramycin by Silver Nanoparticles against Pseudomonas aeruginosa Biofilms.
    Habash MB, Goodyear MC, Park AJ, Surette MD, Vis EC, Harris RJ, Khursigara CM.
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848007
    [Abstract] [Full Text] [Related]

  • 23. Efficacy of the combination of tobramycin and a macrolide in an in vitro Pseudomonas aeruginosa mature biofilm model.
    Tré-Hardy M, Nagant C, El Manssouri N, Vanderbist F, Traore H, Vaneechoutte M, Dehaye JP.
    Antimicrob Agents Chemother; 2010 Oct; 54(10):4409-15. PubMed ID: 20696878
    [Abstract] [Full Text] [Related]

  • 24. Aerosolized bovine lactoferrin reduces neutrophils and pro-inflammatory cytokines in mouse models of Pseudomonas aeruginosa lung infections.
    Valenti P, Frioni A, Rossi A, Ranucci S, De Fino I, Cutone A, Rosa L, Bragonzi A, Berlutti F.
    Biochem Cell Biol; 2017 Feb; 95(1):41-47. PubMed ID: 28129511
    [Abstract] [Full Text] [Related]

  • 25. Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions.
    McCaughey G, McKevitt M, Elborn JS, Tunney MM.
    J Cyst Fibros; 2012 May; 11(3):163-72. PubMed ID: 22138067
    [Abstract] [Full Text] [Related]

  • 26. Co-encapsulation of gallium with gentamicin in liposomes enhances antimicrobial activity of gentamicin against Pseudomonas aeruginosa.
    Halwani M, Yebio B, Suntres ZE, Alipour M, Azghani AO, Omri A.
    J Antimicrob Chemother; 2008 Dec; 62(6):1291-7. PubMed ID: 18931388
    [Abstract] [Full Text] [Related]

  • 27. The complex interplay of iron, biofilm formation, and mucoidy affecting antimicrobial resistance of Pseudomonas aeruginosa.
    Oglesby-Sherrouse AG, Djapgne L, Nguyen AT, Vasil AI, Vasil ML.
    Pathog Dis; 2014 Apr; 70(3):307-20. PubMed ID: 24436170
    [Abstract] [Full Text] [Related]

  • 28. Impairment of Pseudomonas aeruginosa Biofilm Resistance to Antibiotics by Combining the Drugs with a New Quorum-Sensing Inhibitor.
    Furiga A, Lajoie B, El Hage S, Baziard G, Roques C.
    Antimicrob Agents Chemother; 2015 Dec 28; 60(3):1676-86. PubMed ID: 26711774
    [Abstract] [Full Text] [Related]

  • 29. Nano into Micro Formulations of Tobramycin for the Treatment of Pseudomonas aeruginosa Infections in Cystic Fibrosis.
    Porsio B, Cusimano MG, Schillaci D, Craparo EF, Giammona G, Cavallaro G.
    Biomacromolecules; 2017 Dec 11; 18(12):3924-3935. PubMed ID: 29111673
    [Abstract] [Full Text] [Related]

  • 30. Interaction between tobramycin and CSA-13 on clinical isolates of Pseudomonas aeruginosa in a model of young and mature biofilms.
    Nagant C, Tré-Hardy M, El-Ouaaliti M, Savage P, Devleeschouwer M, Dehaye JP.
    Appl Microbiol Biotechnol; 2010 Sep 11; 88(1):251-63. PubMed ID: 20625718
    [Abstract] [Full Text] [Related]

  • 31. In Vivo Efficacy of Antimicrobials against Biofilm-Producing Pseudomonas aeruginosa.
    Pawar V, Komor U, Kasnitz N, Bielecki P, Pils MC, Gocht B, Moter A, Rohde M, Weiss S, Häussler S.
    Antimicrob Agents Chemother; 2015 Aug 11; 59(8):4974-81. PubMed ID: 26055372
    [Abstract] [Full Text] [Related]

  • 32. Bovine lactoferrin inhibits the efficiency of invasion of respiratory A549 cells of different iron-regulated morphological forms of Pseudomonas aeruginosa and Burkholderia cenocepacia.
    Berlutti F, Superti F, Nicoletti M, Morea C, Frioni A, Ammendolia MG, Battistoni A, Valenti P.
    Int J Immunopathol Pharmacol; 2008 Aug 11; 21(1):51-9. PubMed ID: 18336731
    [Abstract] [Full Text] [Related]

  • 33. Activity of hypothiocyanite and lactoferrin (ALX-009) against respiratory cystic fibrosis pathogens in sputum.
    Tunney MM, Payne JE, McGrath SJ, Einarsson GG, Ingram RJ, Gilpin DF, Juarez-Perez V, Elborn JS.
    J Antimicrob Chemother; 2018 Dec 01; 73(12):3391-3397. PubMed ID: 30219825
    [Abstract] [Full Text] [Related]

  • 34. Eradication of Pseudomonas aeruginosa biofilms on cultured airway cells by a fosfomycin/tobramycin antibiotic combination.
    Anderson GG, Kenney TF, Macleod DL, Henig NR, O'Toole GA.
    Pathog Dis; 2013 Feb 01; 67(1):39-45. PubMed ID: 23620118
    [Abstract] [Full Text] [Related]

  • 35. In vivo efficacy of a dry powder formulation of ciprofloxacin-copper complex in a chronic lung infection model of bioluminescent Pseudomonas aeruginosa.
    Tewes F, Bahamondez-Canas TF, Moraga-Espinoza D, Smyth HDC, Watts AB.
    Eur J Pharm Biopharm; 2020 Jul 01; 152():210-217. PubMed ID: 32442738
    [Abstract] [Full Text] [Related]

  • 36. Asiatic acid and corosolic acid enhance the susceptibility of Pseudomonas aeruginosa biofilms to tobramycin.
    Garo E, Eldridge GR, Goering MG, DeLancey Pulcini E, Hamilton MA, Costerton JW, James GA.
    Antimicrob Agents Chemother; 2007 May 01; 51(5):1813-7. PubMed ID: 17353241
    [Abstract] [Full Text] [Related]

  • 37. The Semi-Synthetic Peptide Lin-SB056-1 in Combination with EDTA Exerts Strong Antimicrobial and Antibiofilm Activity against Pseudomonas aeruginosa in Conditions Mimicking Cystic Fibrosis Sputum.
    Maisetta G, Grassi L, Esin S, Serra I, Scorciapino MA, Rinaldi AC, Batoni G.
    Int J Mol Sci; 2017 Sep 16; 18(9):. PubMed ID: 28926942
    [Abstract] [Full Text] [Related]

  • 38. Antibiofilm activity of lactoferrin-derived synthetic peptides against Pseudomonas aeruginosa PAO1.
    Ramamourthy G, Vogel HJ.
    Biochem Cell Biol; 2021 Feb 16; 99(1):138-148. PubMed ID: 32871093
    [Abstract] [Full Text] [Related]

  • 39. A component of innate immunity prevents bacterial biofilm development.
    Singh PK, Parsek MR, Greenberg EP, Welsh MJ.
    Nature; 2002 May 30; 417(6888):552-5. PubMed ID: 12037568
    [Abstract] [Full Text] [Related]

  • 40. Mini-review: Lactoferrin: a bioinspired, anti-biofilm therapeutic.
    Ammons MC, Copié V.
    Biofouling; 2013 May 30; 29(4):443-55. PubMed ID: 23574002
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.